Blue Cross Blue Shield of Minnesota will eliminate out-of-pocket costs for its fully insured customers, while UCare will cap the costs at $25 a month.
Medtronic now will launch a pivotal trial of the experimental infusion sets, not pictured here, with the aim of bringing them to market.
How the founder of Integrated Medical Sensors was motivated to develop better blood sugar monitoring options by his mother’s diabetes diagnosis.
That was just one of the alarming findings from a study of Medicare recipients conducted, in part, by T1D Exchange Patient-Centered Research.
Researchers recently published promising results from a mouse study on the use of an asthma drug to inhibit the early stages of retinopathy.
Dexcom officials shared this news and more details about its pipeline of diabetes technology in a recent earnings call.
Presenters, including members of the T1D Exchange Quality Improvement Collaborative, discussed ways to raise awareness of the upside of CGM use among the patient population.
An overview of this important blood sugar management technology, provided by Michael-John L. Smith, RN, BSN, CCDTC, the Clinical Leader at Nationwide Children’s Hospital in Columbus, Ohio.
The research, conducted by T1D Exchange Patient-Centered Research, points to the need for greater psychological and emotional support for people with type 1 diabetes.
The study is part of a growing body of research pointing to the need for emotional and psychological support in blood sugar management.
Already a Member?
This pioneering effort provides a mobile-friendly platform for people throughout the U.S. to participate online and share information about their type 1 diabetes